{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.1","upperLimit":"6","value":"3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"164"}],"units":"Participants"}],"description":"Average number of years for survival post transplant where overall survival time is measured from date of transplant to disease progression or death for any reason.","dispersionType":"Full Range","groups":[{"description":"Busulfan 32 mg/m\\^2 intravenous (IV) for 1 Day then 130 mg/m\\^2 IV for 4 Days; and Melphalan 70 mg/m\\^2 IV for 2 Days","id":"OG000","title":"Busulfan + Melphalan"}],"paramType":"MEAN","populationDescription":"Analysis by protocol","reportingStatus":"POSTED","timeFrame":"Baseline(transplantation) to disease progression or death for any reason, up to 6 years.","title":"Average Overall Survival Time","type":"PRIMARY","unitOfMeasure":"years"}